The NextFerm pitch at Israel’s AgriFood Summit 2021.
Presented by NextFerm’s CEO Boaz Noy.
Fermentation: the next frontier of alternative proteins | World Economic Forum
Read more
מודעה בדבר כינוסה של אסיפה כללית מיוחדת של בעלי המניות של החברה
ניתנת בזה הודעה, כי אסיפה כללית מיוחדת של החברה תתכנס ביום 7 באפריל 2021, בשעה 12:00 במשרדי עוה”ד של החברה- מיתר עורכי […]
Why Astaferm is the Ideal Astaxanthin for Gummies
Nutritional Outlook’s Jen Grebow and Elzaphan (Elz) Hotam of NextFerm Technologies discuss what makes AstafermTM astaxanthin special and why it’s ideal for the gummy format.
Why Astaferm is the Ideal Astaxanthin for Gummies
Nutritional Outlook’s Jen Grebow and Elzaphan (Elz) Hotam of NextFerm Technologies discuss what makes AstafermTM astaxanthin special and why it’s ideal for the gummy format.
AstafermTM Gummies: Astaxanthin and Vitamin C as the ultimate antioxidant protection in a vegan-friendly gummy
Recent advancements in fermentation technology have made possible for a new form of astaxanthin to emerge. That form of astaxanthin is having multiple advantages over the generic algae-derived astaxanthin, mainly with its high potency and favorable flavor, as well as its texture profile.
Nextferm’s ProteVin awarded third place in Calcalist’s FoodTech innovation start-up contest
NextFerm, an Israeli food-tech start-up has previously launched Astaferm, a yeast-derived astaxanthin
Nextferm’s ProteVin awarded 3rd place in Calcalist’s FoodTech innovation startup contest.
ProteVinTM is the first vegan protein delivering flavor, nutrition and performance, thus overcoming current plant protein’s main limitations.
Antioxidants in 2020: Their next phase of growth
Antioxidants represent a staple category in the dietary supplement market. But there has always been fierce debate about how much consumers really understand about the term antioxidants. Plenty of people support the term and believe in its health relevance, and yet others think antioxidants has lost a lot of its meaning over time.
NextFerm wins SME phase 1 grant from EU Horizon 2020 program
Horizon 2020, the EU’s largest research and innovation program, has awarded an SME phase 1 grant to NextFerm. This grant will enable NextFerm to continue its development for its groundbreaking AstafermTM a yeast-derived, fermented astaxanthin technology for human nutrition.
